MX9710291A - Inhibidores ligantes de proteinas de fijacion con factor de crecimiento del tipo de insulina y metodos de uso para los mismos. - Google Patents
Inhibidores ligantes de proteinas de fijacion con factor de crecimiento del tipo de insulina y metodos de uso para los mismos.Info
- Publication number
- MX9710291A MX9710291A MX9710291A MX9710291A MX9710291A MX 9710291 A MX9710291 A MX 9710291A MX 9710291 A MX9710291 A MX 9710291A MX 9710291 A MX9710291 A MX 9710291A MX 9710291 A MX9710291 A MX 9710291A
- Authority
- MX
- Mexico
- Prior art keywords
- insulin
- methods
- growth factor
- binding proteins
- ligand inhibitors
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title abstract 4
- 239000003446 ligand Substances 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 3
- 102000028416 insulin-like growth factor binding Human genes 0.000 title abstract 2
- 108091022911 insulin-like growth factor binding Proteins 0.000 title abstract 2
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 102000004218 Insulin-Like Growth Factor I Human genes 0.000 abstract 1
- 108090001117 Insulin-Like Growth Factor II Proteins 0.000 abstract 1
- 102000048143 Insulin-Like Growth Factor II Human genes 0.000 abstract 1
- 102000013275 Somatomedins Human genes 0.000 abstract 1
- 150000003384 small molecules Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/65—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Neurology (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Obesity (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dermatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
Los métodos para aumentar el nivel de las proteínas libres biologicamente activas, incluyendo los factores de crecimiento del tipo de insulina, y se proporciona un método para el tratamiento de condiciones de respueta IGF. Los métodos generalmente comprendidos que administran uno o más inhibidores ligantes que inhiben la fijacion de la proteína a una o más proteínas de fijacion con factores de crecimiento del tipo de insulina. Los inhibidores ligantes adecuados incluyen análogos de IGF-1 o IGF-II e inhibidores de pequeñas moléculas.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US63393496A | 1996-04-17 | 1996-04-17 | |
| US633934 | 1996-04-17 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX9710291A true MX9710291A (es) | 1998-08-30 |
| MXPA97010291A MXPA97010291A (es) | 1998-11-12 |
Family
ID=
Also Published As
| Publication number | Publication date |
|---|---|
| CA2224859A1 (en) | 1997-10-23 |
| AU2676297A (en) | 1997-11-07 |
| EP0854884A1 (en) | 1998-07-29 |
| WO1997039032A1 (en) | 1997-10-23 |
| JPH11508608A (ja) | 1999-07-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ227788A (en) | Peptide having growth hormone regulatory effects, and compositions | |
| AU1955388A (en) | Method for potentiating and inhibiting insulin-like growth factor activity | |
| DE69713112D1 (de) | Zusammensetzungen und methoden zur behandlung von infektionen unter verwendung von indolicidin-analogen | |
| DE69835279D1 (de) | Zusammensetzungen und verfahren zur behandlung von infektionen unter verwendung von kationischen peptiden allein oder in kombination mit antibiotika | |
| MY125556A (en) | Aqueous formulations of peptide | |
| DE69520668T2 (de) | Antimikrobielle zubereitungen mit breitem spektrum und verfahren zu ihrer nutzung | |
| DE69004966D1 (de) | Antikoagulierendes protein. | |
| HK1038307A1 (en) | Thymosin beta 4 promotes wound repair. | |
| PL319833A1 (en) | Compounds and composition for carrying active media | |
| UA43348C2 (uk) | Водна фармацевтична композиція, що включає фактор росту нерва (варіанти) та ліофілізований фармацевтичний склад | |
| AU3847997A (en) | Inhibitors of the interaction between P53 and MDM2 | |
| MY124214A (en) | Compositions for promoting crowth | |
| ATE203165T1 (de) | Behandlung des partiellen wachstumshormon- unempfindlichkeitssyndromes | |
| EE9700225A (et) | Meetod diabetes mellituse raviks, kasutades KKF | |
| IL187254A (en) | ANTISENSE NUCLEOTIDES, COMPOSITIONS COMPRISING THEREOF AND THEIR USE IN MODULATING ACTIVATION OF NF-kB | |
| HK1008347A1 (en) | Dorsal tissue affecting factor and compositions | |
| GR3024379T3 (en) | Peptides with organo-protective activity, the process for preparing them and their use in therapy | |
| DE60012517D1 (de) | Methoden zur behandlung von diabetes | |
| HK1037722A1 (en) | Modulating multiple lineage kinase proteins. | |
| WO2002092013A3 (en) | Methods for treating liver disease and liver damage with growth hormone and foxm1b | |
| DE69735583D1 (de) | Semisynthetisches verfahren zur herstellung von didemninanalogen | |
| DE69510356D1 (de) | Anti-sickling beta-globin,zusammensetzung und verfahren zur behandlung von sichelzellanämie | |
| WO2002058589A3 (en) | Agents and methods for promoting bone growth | |
| WO1994010207A3 (en) | Truncated insulin-like growth factor binding proteins having mitogenic activity | |
| EP1080724A4 (en) | COMPOSITIONS FOR REDUCING MTP ACTIVITY |